Cellect Biotechnology Ltd. Warrants to Purchase ADRs
APOPW
APOPW was delisted on the 3rd of August, 2021.
1 hedge funds and large institutions have $2K invested in Cellect Biotechnology Ltd. Warrants to Purchase ADRs in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.56K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $2K | +$1.56K | +19,760 | New |
|
APOPW Hedge Fund Activity: Q3 2020 in Review
1 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) for Q3 2020, worth a combined $2K.
Buyers outnumbered sellers: 1 fund opened new APOPW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.56K.
- 1 institutional investor held Cellect Biotechnology Ltd. Warrants to Purchase ADRs (APOPW) as of Q3 2020, up from 0 in Q2 2020.
- Funds reported $2K of Cellect Biotechnology Ltd. Warrants to Purchase ADRs stock for Q3 2020.
- 1 fund opened new Cellect Biotechnology Ltd. Warrants to Purchase ADRs positions in Q3 2020 and 0 closed out, a net change of +1 holder.
- The largest Cellect Biotechnology Ltd. Warrants to Purchase ADRs buyer in Q3 2020 was Susquehanna International Group, an estimated $1.56K added.
Based on aggregated 13F filings for Q3 2020.